MindWalk’s Q3 Revenue Climbs 52% to C$4.2M with First Recurring LensAI Deal
CERT•MindWalk reported C$4.2 million revenue in its fiscal Q3, marking a 52% year-over-year increase and doubling U.S. sales. The company also secured its first recurring one-year LensAI platform contract and leverages a proprietary HYFT® Technology context layer linking 660 million biological patterns and 25 billion relationships.
1. Strategic Shift to Biological Context Layer
MindWalk has positioned the biological context layer as its core strategic asset, arguing that connected, curated biological knowledge offers durable advantages over commoditized AI models and reduces costly hallucinations in drug discovery workflows.
2. Q3 Financial Performance and Recurring Deal
For fiscal third quarter ended January 31, 2026, MindWalk reported C$4.2 million revenue, up 52% year-over-year with U.S. revenue doubling, and signed its first one-year LensAI platform contract, marking the company’s inaugural recurring platform-revenue agreement.
3. HYFT® Technology and Product Offerings
MindWalk’s proprietary HYFT® Technology spans two decades of curation, linking 660 million biological patterns and 25 billion relationships to underpin its ReefIQ™ context layer and LensAI™ reasoning platform for target discovery and agentic workflows.
4. Early Validation and Growth Outlook
The platform also demonstrated real-world validation by predicting preclinical dengue outcomes before immunization, and the company intends to scale its recurring deal structure across enterprise AI clients as it expands offerings.
